RESOURCES

---

Kuali Quickguides

Kuali Quickguides provide step-wise instructions for using the Kuali Research electronic submission system:

• Accessing Kuali Research
   
• Creating and Submitting IBC Protocols in Kuali  (including initial and post-approval applications)
   
• Reviewing IBC Protocol Applications

 

Forms

• Applicable NIH Guidelines Sections (form for submitting with Kuali IBC protocol)
  • Version 1.0 (for studies using older protocol templates)
  • Version 2.1 (for studies using current protocol template)
     
• Specific Treatment for Research Material Exposure  (form for submitting with Kuali IBC protocol)

 

Biosafety Reference Guides

• Viral Vector Biosafety Reference Guide
   
• Animal Biosafety Reference Guide

 

NIH Guidelines

The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) detail safety practices and containment procedures for basic and clinical research involving recombinant or synthetic nucleic acid molecules, including the creation and use of organisms and viruses containing recombinant or synthetic nucleic acid molecules.It is highly recommended that this document be reviewed before submission of an IBC protocol. 

• NIH Guidelines - April 2024 (PDF) 
   
• NIH Guidelines - April 2024(HTML)

 

Other Resources 

The following websites may be useful for understanding laboratory biosafety issues and/or completing IBC applications:

• Compliance Flowchart for Establishing a Lab at LSUHSC-NO

• The Association for Biosafety and Biosecurity

  • ABSA Laboratory-Acquired Infections Database - Useful for guidance on proper PPE when handling infectious agents in laboratory setting, exposure reporting based on real world incidents, and recommended biosafety practices to avoid LAI exposures.
     
  • ABSA Risk Group Database - Useful for assessing risk group of organisms that you may use in your research.
     
• Comprehensive Biosafety Guidance and Resources provided by the NIH's Office of Science Policy  - Links provided by NIH to other Federal Agencies overseeing biosafety in research.
   
• NIH Office of Science Policy: Division of Biosafety, Biosecurity, and Emerging Biotechnology Policy